Insider Trading activities of Clearside Biomedical, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Clearside Biomedical, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Clearside Biomedical, Inc. since year 2005. Table 2 shows the detailed insider transactions of Clearside Biomedical, Inc. since 2005. The reporting company's ticker symbol is CLSD. The reporting company's CIK number is 1539029.
The total value of stock buying since 2005 is $10,408,186.
The total value of stock sales since 2005 is $5,486,707.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Clearside Biomedical, Inc. (CLSD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 35,000 $217,550 0 $0
2017-11 0 $0 35,000 $245,100 0 $0
2017-10 0 $0 43,000 $362,420 0 $0
2017-09 0 $0 40,500 $305,265 0 $0
2017-08 7,100 $50,165 24,500 $185,490 0 $0
2017-07 0 $0 8,000 $78,000 0 $0
2017-06 0 $0 8,000 $63,080 0 $0
2017-05 1,100 $8,800 76,485 $651,985 0 $0
2017-04 0 $0 76,485 $571,344 0 $0
2017-03 21,264 $149,234 68,485 $449,543 0 $0
2017-02 0 $0 68,485 $518,835 0 $0
2017-01 0 $0 213,583 $1,835,631 0 $0
2016-06 1,457,141 $10,199,987 352 $2,464 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Clearside Biomedical, Inc. insiders (CLSD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-07 Thorp Clay (Director) Sale 5,000 6.13 30,650
2017-12-06 Thorp Clay (Director) Sale 15,000 6.09 91,350
2017-12-05 Thorp Clay (Director) Sale 15,000 6.37 95,550
2017-11-16 Thorp Clay (Director) Sale 5,000 6.99 34,950
2017-11-15 Thorp Clay (Director) Sale 15,000 6.99 104,850
2017-11-14 Thorp Clay (Director) Sale 15,000 7.02 105,300
2017-10-19 White Daniel H. (President and CEO) Sale 4,000 7.81 31,240
2017-10-18 White Daniel H. (President and CEO) Sale 4,000 7.82 31,280
2017-10-05 Thorp Clay (Director) Sale 6,000 8.34 50,040
2017-10-04 Thorp Clay (Director) Sale 14,000 8.59 120,260
2017-10-03 Thorp Clay (Director) Sale 15,000 8.64 129,600
2017-09-15 Thorp Clay (Director) Sale 10,000 7.54 75,400
2017-09-14 Thorp Clay (Director) Sale 6,000 7.52 45,120
2017-09-13 Thorp Clay (Director) Sale 8,500 7.49 63,665
2017-09-08 White Daniel H. (President and CEO) Sale 6,000 7.63 45,780
2017-09-07 White Daniel H. (President and CEO) Sale 10,000 7.53 75,300
2017-08-15 Shaffer Christy L (Director) Buy 1,100 7.00 7,700
2017-08-14 Deignan Charles A. (Chief Financial Officer) Buy 1,000 7.07 7,065
2017-08-11 Cagle Gerald D. (Director) Buy 5,000 7.08 35,400
2017-08-09 Thorp Clay (Director) Sale 15,000 7.30 109,500
2017-08-08 Thorp Clay (Director) Sale 5,000 7.98 39,900
2017-08-07 Thorp Clay (Director) Sale 4,500 8.02 36,090
2017-07-20 White Daniel H. (President and CEO) Sale 4,000 9.71 38,840
2017-07-19 White Daniel H. (President and CEO) Sale 4,000 9.79 39,160
2017-06-14 White Daniel H. (President and CEO) Sale 4,000 7.99 31,960
2017-06-13 White Daniel H. (President and CEO) Sale 4,000 7.78 31,120
2017-05-22 Shaffer Christy L (Director) Buy 1,100 8.00 8,800
2017-05-19 Thorp Clay (Director) Sale 15,000 8.31 124,650
2017-05-18 White Daniel H. (President and CEO) Sale 4,000 8.44 33,760
2017-05-18 Thorp Clay (Director) Sale 9,000 8.44 75,960
2017-05-17 White Daniel H. (President and CEO) Sale 4,000 8.38 33,520
2017-05-17 Thorp Clay (Director) Sale 19,000 8.39 159,410
2017-05-16 Thorp Clay (Director) Sale 9,544 8.61 82,173
2017-05-15 Thorp Clay (Director) Sale 15,941 8.94 142,512
2017-04-19 Thorp Clay (Director) Sale 2,030 7.37 14,961
2017-04-18 Thorp Clay (Director) Sale 44,455 7.48 332,523
2017-04-17 Thorp Clay (Director) Sale 22,000 7.43 163,460
2017-04-04 White Daniel H. (President and CEO) Sale 4,000 7.54 30,160
2017-04-03 White Daniel H. (President and CEO) Sale 4,000 7.56 30,240
2017-03-27 Cagle Gerald D. (Director) Buy 14,064 7.10 99,854
2017-03-20 Shaffer Christy L (Director) Buy 2,200 6.90 15,180
2017-03-16 Thorp Clay (Director) Sale 21,485 6.77 145,453
2017-03-16 Cagle Gerald D. (Director) Buy 5,000 6.84 34,200
2017-03-15 Thorp Clay (Director) Sale 47,000 6.47 304,090
2017-02-22 Thorp Clay (Director) Sale 2,000 7.49 14,980
2017-02-21 Thorp Clay (Director) Sale 25,000 7.55 188,750
2017-02-17 Thorp Clay (Director) Sale 10,000 7.54 75,400
2017-02-16 Thorp Clay (Director) Sale 14,000 7.58 106,120
2017-02-15 Thorp Clay (Director) Sale 17,485 7.64 133,585
2017-01-20 Thorp Clay (Director) Sale 8,000 7.77 62,160
2017-01-19 Thorp Clay (Other) Sale 29,555 8.23 243,096
2017-01-18 Thorp Clay (Other) Sale 47,715 8.64 412,257
2017-01-17 Thorp Clay (Other) Sale 38,172 8.92 340,493
2016-06-07 Hatteras Venture Partners Iv Sbic, Lp (10% Owner) Buy 414,286 7.00 2,900,002
2016-06-07 Hatteras Venture Partners Iv Sbic, Lp (10% Owner) Sale 69 7.00 483
2016-06-07 White Daniel H. (President and CEO) Sale 3 7.00 21
2016-06-07 Deignan Charles A. (Chief Financial Officer) Sale 2 7.00 14
2016-06-07 Thorp Clay (Director) Buy 892,856 7.00 6,249,992
2016-06-07 Thorp Clay (Director) Sale 207 7.00 1,449
2016-06-07 Cagle Gerald D. (Director) Sale 2 7.00 14
2016-06-07 Rusnanomedinvest Llc (10% Owner) Buy 42,857 7.00 299,999

Insider trading activities including stock purchases, stock sales, and option exercises of CLSD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Clearside Biomedical, Inc. (symbol CLSD, CIK number 1539029) see the Securities and Exchange Commission (SEC) website.